Trials / Completed
CompletedNCT02902523
Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single-dosing, 2x2 crossover study to compare the safety and pharmacokinetics of HUG116 tablet(Tenofovir Disoproxil) with Viread® tablet(Tenofovir Disoproxil Fumarate) in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viread® tablet 300mg | Single dose administration(PO) in the fasted state |
| DRUG | HUG116 tablet 245mg | Single dose administration(PO) in the fasted state |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2016-10-01
- Completion
- 2016-11-01
- First posted
- 2016-09-15
- Last updated
- 2018-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02902523. Inclusion in this directory is not an endorsement.